Search Orphan Drug Designations and Approvals
-
Generic Name: | monoclonal antibody targeting eotaxin-2 |
---|---|
Date Designated: | 10/29/2015 |
Orphan Designation: | Treatment of idiopathic pulmonary fibrosis. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ChemomAb, Ltd. 6 Hanehoset St. Tel Aviv Israel The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-